Increased MMPs expression and decreased contraction in the rat myometrium during pregnancy and in response to Prolonged stretch and sex hormones

American Journal of Physiology - Endocrinology and Metabolism

Volumn 303, Issue 1, 2012, Pages

  Yin, Zongzhi ^a   Sada, Alaa A ^a   Reslan, Ossama M ^a   Narula, Neha ^a   Khalil, Raouf A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Estrogen; Matrix metalloproteinases; Progesterone; Uterus

Indexed keywords

BATIMASTAT; CIPEMASTAT; ESTRADIOL; GELATINASE A; GELATINASE B; MATRILYSIN; MESSENGER RNA; OXYTOCIN; PROGESTERONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; MUSCLE ISOMETRIC CONTRACTION; MUSCLE STRETCHING; MYOMETRIUM; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; UTERUS RELAXATION; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; ENZYME INDUCTION; ESTRADIOL; FEMALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MUSCLE RELAXATION; MUSCLE TONUS; MYOGRAPHY; MYOMETRIUM; OSMOLAR CONCENTRATION; OXYTOCIN; PHYSICAL STIMULATION; PREGNANCY; PROGESTERONE; PROTEASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; UTERINE CONTRACTION;

EID: 84863646236     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00553.2011     Document Type: Article

References (70)

1. Ang VT, Jenkins JS. Neurohypophysial hormones in the adrenal medulla. J Clin Endocrinol Metab 58: 688-691, 1984.
2. Arthur P, Taggart MJ, Zielnik B, Wong S, Mitchell BF. Relationship between gene expression and function of uterotonic systems in the rat during gestation, uterine activation and both term and preterm labour. J Physiol 586: 6063-6076, 2008.
3. Awad AE, Kandalam V, Chakrabarti S, Wang X, Penninger JM, Davidge ST, Oudit GY, Kassiri Z. Tumor necrosis factor induces matrix metalloproteinases in cardiomyocytes and cardiofibroblasts differentially via superoxide production in a PI3K γ-dependent manner. Am J Physiol Cell Physiol 298: C679-C692, 2010.
4. 2+ oscillations in myometrial cells. Toxicol Lett 165: 133-141, 2006.
5. Brown S, Margarida B, Li Z, Korta LP, Tanaka Y, Fridman R, Mobashery S. Potent and selective mechanism-based Inhibition of gelatinases. J Am Chem Soc 122: 6799-6800, 2000.
6. 2+ responses in human myometrial cells. Biol Reprod 60: 777-782, 1999.
7. Challis JRG, Matthews SG, Gibb W, Lye SJ. Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev 21: 514-550, 2000.
8. Chang H, Shyu KG, Wang BW, Kuan P. Regulation of hypoxiainducible factor-1 α by cyclical mechanical stretch in rat vascular smooth muscle cells. Clin Sci (Lond) 105: 447-456, 2003.
9. 2+ entry mechanisms of vascular contraction. J Vasc Surg 40: 1001-1010, 2004.
10. Cid MC, Kleinman HK, Grant DS, Schnaper HW, Fauci AS, Hoffman GS. Estradiol enhances leukocyte binding to tumor necrosis factor (TNF)-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selectin, intercellular adhesion molecule type 1, and vascular cell adhesion molecule type 1. J Clin Invest 93: 17-25, 1994.
11. 2+ entry mechanisms of arterial vasoconstriction by sex hormones. Clin Exp Pharmacol Physiol 26: 707-715, 1999.
12. Daikoku T, Matsumoto H, Gupta RA, Das SK, Gassmann M, DuBois RN, Dey SK. Expression of hypoxia-inducible factors in the peri-implantation mouse uterus is regulated in a cell-specific and ovarian steroid hormone-dependent manner. Evidence for differential function of HIFs during early pregnancy. J Biol Chem 278: 7683-7691, 2003.
13. Davies B, Brown PD, East N, Crimmin MJ, Balkwill FR. A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Res 53: 2087-2091, 1993.
14. Edwards KM, Mills PJ. Effects of estrogen versus estrogen and progesterone on cortisol and interleukin-6. Maturitas 61: 330-333, 2008.
15. Fanchin R, Righini C, de Ziegler D, Olivennes F, Ledee N, Frydman R. Effects of vaginal progesterone administration on uterine contractility at the time of embryo transfer. Fertil Steril 75: 1136-1140, 2001.
16. Fields PA, Eldridge RK, Fuchs AR, Roberts RF, Fields MJ. Human placental and bovine corpora luteal oxytocin. Endocrinology 112: 1544-1546, 1983.
17. Fortunato SJ, Menon R. Distinct molecular events suggest different pathways for preterm labor and premature rupture of membranes. Am J Obstet Gynecol 184: 1399-1405, 2001.
18. 2+ in human myometrial cells. Acta Obstet Gynecol Scand 79: 174-179, 2000.
19. Fujiwara S, Nakagawa K, Harada H, Nagato S, Furukawa K, Teraoka M, Seno T, Oka K, Iwata S, Ohnishi T. Silencing hypoxia-inducible factor-1 α inhibits cell migration and invasion under hypoxic environment in malignant gliomas. Int J Oncol 30: 793-802, 2007.
20. Gaber T, Dziurla R, Tripmacher R, Burmester GR, Buttgereit F. Hypoxia inducible factor (HIF) in rheumatology: low O2! See what HIF can do! Ann Rheum Dis 64: 971-980, 2005.
21. Grams F, Brandstetter H, D'Alo S, Geppert D, Krell HW, Leinert H, Livi V, Menta E, Oliva A, Zimmermann G, Gram F, Livi VE. Pyrimidine-2,4,6-triones: a new effective and selective class of matrix metalloproteinase inhibitors. Biol Chem 382: 1277-1285, 2001.
22. Harris LK, Smith SD, Keogh RJ, Jones RL, Baker PN, Knofler M, Cartwright JE, Whitley GS, Aplin JD. Trophoblast-and vascular smooth muscle cell-derived MMP-12 mediates elastolysis during uterine spiral artery remodeling. Am J Pathol 177: 2103-2115, 2010.
23. He YY, Cai B, Yang YX, Liu XL, Wan XP. Estrogenic G proteincoupled receptor 30 signaling is involved in regulation of endometrial carcinoma by promoting proliferation, invasion potential, and interleukin-6 secretion via the MEK/ERK mitogen-activated protein kinase pathway. Cancer Sci 100: 1051-1061, 2009.
24. Kim CH, Cho YS, Chun YS, Park JW, Kim MS. Early expression of myocardial HIF-1 α in response to mechanical stresses: regulation by stretch-activated channels and the phosphatidylinositol 3-kinase signaling pathway. Circ Res 90: E25-E33, 2002.
25. Kizaki K, Ushizawa K, Takahashi T, Yamada O, Todoroki J, Sato T, Ito A, Hashizume K. Gelatinase (MMP-2 and-9) expression profiles during gestation in the bovine endometrium. Reprod Biol Endocrinol 6: 66, 2008.
26. Kleifeld O, Kotra LP, Gervasi DC, Brown S, Bernardo MM, Fridman R, Mobashery S, Sagi I. X-ray absorption studies of human matrix metalloproteinase-2 (MMP-2) bound to a highly selective mechanismbased inhibitor. Comparison with the latent and active forms of the enzyme. J Biol Chem 276: 17125-17131, 2001.
27. Lee JD, Jeng SY, Lee TH. Increased expression of hypoxia-inducible factor-1 α in the internal spermatic vein of patients with varicocele. J Urol 175: 1045-1048, 2006.
28. Lein M, Jung K, Ortel B, Stephan C, Rothaug W, Juchem R, Johannsen M, Deger S, Schnorr D, Loening S, Krell HW. The new synthetic matrix metalloproteinase inhibitor (Roche 28-2653) reduces tumor growth and prolongs survival in a prostate cancer standard rat model. Oncogene 21: 2089-2096, 2002.
29. Lekontseva O, Jiang Y, Davidge ST. Estrogen replacement increases matrix metalloproteinase contribution to vasoconstriction in a rat model of menopause. J Hypertens 27: 1602-1608, 2009.
30. Levy C, Robel P, Gautray JP, De Brux J, Verma U, Descomps B, Baulieu EE. Estradiol and progesterone receptors in human endometrium: normal and abnormal menstrual cycles and early pregnancy. Am J Obstet Gynecol 136: 646-651, 1980.
31. Lim CS, Qiao X, Reslan OM, Xia Y, Raffetto JD, Paleolog E, Davies AH, Khalil RA. Prolonged mechanical stretch is associated with upregulation of hypoxia-inducible factors and reduced contraction in rat inferior vena cava. J Vasc Surg 53: 764-773, 2011.
32. Lucovnik M, Kuon RJ, Chambliss LR, Maner WL, Shi SQ, Shi L, Balducci J, Garfield RE. Progestin treatment for the prevention of preterm birth. Acta Obstet Gynecol Scand 90: 1057-1069, 2011.
33. Lyons CA, Beharry KD, Nishihara KC, Akmal Y, Ren ZY, Chang E, Nageotte MP. Regulation of matrix metalloproteinases (type IV collagenases) and their inhibitors in the virgin, timed pregnant, and postpartum rat uterus and cervix by prostaglandin E2-cyclic adenosine monophosphate. Am J Obstet Gynecol 187: 202-208, 2002.
34. Maquoi E, Sounni NE, Devy L, Olivier F, Frankenne F, Krell HW, Grams F, Foidart JM, Noel A. Anti-invasive, antitumoral, and antiangiogenic efficacy of a pyrimidine-2,4,6-trione derivative, an orally active and selective matrix metalloproteinases inhibitor. Clin Cancer Res 10: 4038-4047, 2004.
35. Matsuzaki S, Maleysson E, Darcha C. Analysis of matrix metalloproteinase-7 expression in eutopic and ectopic endometrium samples from patients with different forms of endometriosis. Hum Reprod 25: 742-750, 2010.
36. Mazzuca MQ, Wlodek ME, Dragomir NM, Parkington HC, Tare M. Uteroplacental insufficiency programs regional vascular dysfunction and alters arterial stiffness in female offspring. J Physiol 588: 1997-2010, 2010.
37. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 340: 1801-1811, 1999.
38. Milkiewicz M, Doyle JL, Fudalewski T, Ispanovic E, Aghasi M, Haas TL. HIF-1 α and HIF-2 α play a central role in stretch-induced but not shear-stress-induced angiogenesis in rat skeletal muscle. J Physiol 583: 753-766, 2007.
39. Milkiewicz M, Haas TL. Effect of mechanical stretch on HIF-1 α and MMP-2 expression in capillaries isolated from overloaded skeletal muscles: laser capture microdissection study. Am J Physiol Heart Circ Physiol 289: H1315-H1320, 2005.
40. Monckedieck V, Sannecke C, Husen B, Kumbartski M, Kimmig R, Totsch M, Winterhager E, Grummer R. Progestins inhibit expression of MMPs and of angiogenic factors in human ectopic endometrial lesions in a mouse model. Mol Hum Reprod 15: 633-643, 2009.
41. Naruse K, Lash GE, Innes BA, Otun HA, Searle RF, Robson SC, Bulmer JN. Localization of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitors for MMPs (TIMPs) in uterine natural killer cells in early human pregnancy. Hum Reprod 24: 553-561, 2009.
42. Olson MW, Gervasi DC, Mobashery S, Fridman R. Kinetic analysis of the binding of human matrix metalloproteinase-2 and-9 to tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2. J Biol Chem 272: 29975-29983, 1997.
43. Parkington HC, Coleman HA. Ionic mechanisms underlying action potentials in myometrium. Clin Exp Pharmacol Physiol 15: 657-665, 1988.
44. Patel J, Landers K, Mortimer RH, Richard K. Regulation of hypoxia inducible factors (HIF) in hypoxia and normoxia during placental development. Placenta 31: 951-957, 2010.
45. Perusquia M, Navarrete E. Evidence that 17 α-estradiol is biologically active in the uterine tissue: antiuterotonic and antiuterotrophic action. Reprod Biol Endocrinol 3: 30, 2005.
46. Petersen W, Varoga D, Zantop T, Hassenpflug J, Mentlein R, Pufe T. Cyclic strain influences the expression of the vascular endothelial growth factor (VEGF) and the hypoxia inducible factor 1 α (HIF-1 α) in tendon fibroblasts. J Orthop Res 22: 847-853, 2004.
47. Phillippe M, Basa A. Effects of sodium and calcium channel blockade on cytosolic calcium oscillations and phasic contractions of myometrial tissue. J Soc Gynecol Investig 4: 72-77, 1997.
48. 2+]e-dependent mechanisms of venous smooth muscle contraction. Role of RGD peptides. J Surg Res 159: 755-764, 2010.
49. Raffetto JD, Khalil RA. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol 75: 346-359, 2008.
50. Raffetto JD, Qiao X, Koledova VV, Khalil RA. Prolonged increases in vein wall tension increase matrix metalloproteinases and decrease constriction in rat vena cava: potential implications in varicose veins. J Vasc Surg 48: 447-456, 2008.
51. Raffetto JD, Ross RL, Khalil RA. Matrix metalloproteinase 2-induced venous dilation via hyperpolarization and activation of K+ channels: relevance to varicose vein formation. J Vasc Surg 45: 373-380, 2007.
52. Risberg A, Olsson K, Lyrenas S, Sjoquist M. Plasma vasopressin, oxytocin, estradiol, and progesterone related to water and sodium excretion in normal pregnancy and gestational hypertension. Acta Obstet Gynecol Scand 88: 639-646, 2009.
53. Roy SC, Ghosh J. Dynamic in vivo changes in the activities of gelatinases, matrix metalloproteinases (MMPs), and tissue inhibitor of metalloproteinases (TIMPs) in buffalo (Bubalus bubalis) uterine luminal fluid during estrous cycle and early pregnancy. Mol Reprod Dev 77: 944-953, 2010.
54. Russo LA, Peano BJ, Trivedi SP, Cavalcanto TD, Olenchock BA, Caruso JA, Smolock AR, Vishnevsky O, Gardner RM. Regulated expression of matrix metalloproteinases, inflammatory mediators, and endometrial matrix remodeling by 17 β-estradiol in the immature rat uterus. Reprod Biol Endocrinol 7: 124, 2009.
55. Scott PA, Tremblay A, Brochu M, St-Louis J. Vasorelaxant action of 17 β-estradiol in rat uterine arteries: role of nitric oxide synthases and estrogen receptors. Am J Physiol Heart Circ Physiol 293: H3713-H3719, 2007.
56. Selvais C, Gaide Chevronnay HP, Lemoine P, Dedieu S, Henriet P, Courtoy PJ, Marbaix E, Emonard H. Metalloproteinase-dependent shedding of low-density lipoprotein receptor-related protein-1 ectodomain decreases endocytic clearance of endometrial matrix metalloproteinase-2 and-9 at menstruation. Endocrinology 150: 3792-3799, 2009.
57. Semenza GL. Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology (Bethesda) 24: 97-106, 2009.
58. Shaco-Levy R, Sharabi S, Benharroch D, Piura B, Sion-Vardy N. Matrix metalloproteinases 2 and 9, E-cadherin, and β-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium. Eur J Obstet Gynecol Reprod Biol 139: 226-232, 2008.
59. Stamatelou F, Deligeoroglou E, Farmakides G, Creatsas G. Abnormal progesterone and corticotropin releasing hormone levels are associated with preterm labour. Ann Acad Med Singapore 38: 1011-1016, 2009.
60. Stock S, Bremme K, Uvnas-Moberg K. Plasma levels of oxytocin during the menstrual cycle, pregnancy and following treatment with HMG. Hum Reprod 6: 1056-1062, 1991.
61. Sunday L, Osuna C, Krause DN, Duckles SP. Age alters cerebrovascular inflammation and effects of estrogen. Am J Physiol Heart Circ Physiol 292: H2333-H2340, 2007.
62. Ulbrich SE, Meyer SU, Zitta K, Hiendleder S, Sinowatz F, Bauersachs S, Buttner M, Frohlich T, Arnold GJ, Reichenbach HD, Wolf E, Meyer HH. Bovine endometrial metallopeptidases MMP14 and MMP2 and the metallopeptidase inhibitor TIMP2 participate in maternal preparation of pregnancy. Mol Cell Endocrinol 332: 48-57, 2011.
63. van Engelen E, Breeveld-Dwarkasing VN, Taverne MA, Everts ME, van der Weijden GC, Rutten VP. MMP-2 expression precedes the final ripening process of the bovine cervix. Mol Reprod Dev 75: 1669-1677, 2008.
64. Wang X, Fu X, Brown PD, Crimmin MJ, Hoffman RM. Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice. Cancer Res 54: 4726-4728, 1994.
65. Wathes DC, Swann RW. Is oxytocin an ovarian hormone? Nature 297: 225-227, 1982.
66. Wathes DC, Swann RW, Pickering BT, Porter DG, Hull MG, Drife JO. Neurohypophysial hormones in the human ovary. Lancet 2: 410-412, 1982.
67. Weiss A, Goldman S, Shalev E. The matrix metalloproteinases (MMPS) in the decidua and fetal membranes. Front Biosci 12: 649-659, 2007.
68. Yener T, Turkkani Tunc A, Aslan H, Aytan H, Cantug Caliskan A. Determination of oestrous cycle of the rats by direct examination: how reliable? Anat Histol Embryol 36: 75-77, 2007.
69. Yue C, Ku CY, Liu M, Simon MI, Sanborn BM. Molecular mechanism of the inhibition of phospholipase C-+3 by protein kinase C. J Biol Chem 275: 30220-30225, 2000.
70. Zhang X, Christenson LK, Nothnick WB. Regulation of MMP-9 expression and activity in the mouse uterus by estrogen. Mol Reprod Dev 74: 321-331, 2007.